SXC Health Solutions SXCI reports its Q4 EPS at $0.26, versus the consensus of $0.27. SXCI reports its Q4 revenue at $499.76 million, versus the consensus of $515.70 million.
SXCI shares gained 1.53% to $47.22 in after-hours trading.
Read more from Benzinga's Company news.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
